(Q38237077)

31 August 2017

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology (English)

1 reference

31 August 2017

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Tom Snelling

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Peter B. McIntyre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Sarah L Sheridan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Katie Frith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Keith Grimwood

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

5 August 2014

1 reference

Expert Review of Vaccines

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1081-1106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Pertussis re-emergence in the post-vaccination era

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

21 January 2018

The pertussis problem.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Epidemiological features of pertussis in the United States, 1980-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Development of a pertussis component vaccine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Re-emergence of pertussis: what are the solutions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Rationale for pertussis booster vaccination throughout life in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

California pertussis epidemic, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Priming with whole-cell versus acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Acellular pertussis vaccine effectiveness for children during the 2009-2010 pertussis epidemic in Queensland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Immunity to Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Dissecting human T cell responses against Bordetella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Systematic review of the effects of pertussis vaccines in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Pertussis in Sweden after the cessation of general immunization in 1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Efficacy of a two-component acellular pertussis vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

The effectiveness of vaccination with whole-cell pertussis vaccine by age group in Poland 1996-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Pertussis vaccine effectiveness after mass immunization of high school students in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Waning immunity to pertussis following 5 doses of DTaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Pertussis vaccine performance in an epidemic year-Oregon, 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Sevenfold rise in likelihood of pertussis test requests in a stable set of Australian general practice encounters, 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Bordetella pertussis strain variation and evolution postvaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

The vaccine containing recombinant pertussis toxin induces early and long-lasting protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

A placebo-controlled trial of a pertussis-toxoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.944167

10.1586/14760584.2014.944167

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25093268%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference